International Vaccine Institute

About

The International Vaccine Institute (IVI) is an independent, nonprofit, international organization that was founded on the belief that the health of children in developing countries can be dramatically improved by the use of new and improved vaccines. Working in collaboration with the international scientific community, public health organizations, governments, and industry, IVI is involved in all areas of the vaccine spectrum – from new vaccine design in the laboratory to vaccine development and evaluation in the field to facilitating sustainable introduction of vaccines in countries where they are most needed.

Created initially as an initiative of the UN Development Programme (UNDP), IVI began formal operations as an independent international organization in 1997 in Seoul, Republic of Korea. Currently, IVI has 35 countries and the World Health Organization (WHO) as signatories to its Establishment Agreement. The Institute has a unique mandate to work exclusively on vaccine development and introduction specifically for people in developing countries, with a focus on neglected diseases affecting these regions.

Vaccines for Developing Countries

IVI focuses on vaccines against infectious diseases affecting the World’s most impoverished. We aim to make vaccines available and accessible for vulnerable populations in developing countries.

Vaccines for Global Health

We live in an increasingly globalized world where new and emerging infectious diseases can become global health threats. IVI also focuses on vaccines against infectious diseases of major global health concern.

Approach

IVI’s approach is based on three components:

• Research: vaccine R&D, translational and field research
• Partnerships: product development partnerships, international research consortia, and networks
• Capacity-building: training, technical assistance, and technology transfers